Fine chemicals company Hovione has passed an inspection by the US
Food and Drug Administration (FDA) at its active pharmaceutical
ingredient (API) manufacturing site in Loures, Portugal, as it
tries to conform with ever-stricter standards.
The Hovione Group revealed its yearly figures for 2005, which
revealed that sales grew by 8 per cent. The company's performance
is in contrast to the pharma fine chemicals sector, which between
2002 and 2004 had an average 14...